Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial
Nicolas Garel; Sara de la Salle; Julien Thibault Lévesque; Alyssa Bensoussan; Juliette Vaugeois; David Erritzoe; Soham Rej; Michael Lifshitz; Stephane Richard-Devantoy; Kyle T. Greenway Current Treatment Options in Rheumatology
· Springer Nature
· 2026-11-14
Аннотация
Communications Medicine, Published online: 14 November 2026; doi:10.1038/s43856-026-01987-8 Garel et al. explore the influence of the personality trait absorption in the MUSIK trial which administered 181 doses of ketamine, with either music or mindfulness, for treatment-resistant depression. Higher absorption is associated with larger antidepressant effects, reduced suicidality, and more mystical experiences, especially with music-based support.
Nicolas Garel; Sara de la Salle; Julien Thibault Lévesque; Alyssa Bensoussan; Juliette Vaugeois; David Erritzoe; Soham Rej; Michael Lifshitz; Stephane Richard-Devantoy; Kyle T. Greenway. Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial. // Current Treatment Options in Rheumatology. – 2026. – URL: https://www.nature.com/articles/s43856-026-01987-8
Nicolas Garel; Sara de la Salle; Julien Thibault Lévesque; Alyssa Bensoussan; Juliette Vaugeois; David Erritzoe; Soham Rej; Michael Lifshitz; Stephane Richard-Devantoy; Kyle T. Greenway (2026). Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial. Current Treatment Options in Rheumatology. https://www.nature.com/articles/s43856-026-01987-8
Nicolas Garel; Sara de la Salle; Julien Thibault Lévesque; Alyssa Bensoussan; Juliette Vaugeois; David Erritzoe; Soham Rej; Michael Lifshitz; Stephane Richard-Devantoy; Kyle T. Greenway. “Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial.” Current Treatment Options in Rheumatology, 2026.
@article{Greenway2026,
title = {Trait absorption association with ketamine’s benefits and drug-context interactions in treatment-resistant depression: exploratory results from the MUSIK randomized clinical trial},
author = {Greenway, Nicolas Garel; Sara de la Salle; Julien Thibault Lévesque; Alyssa Bensoussan; Juliette Vaugeois; David Erritzoe; Soham Rej; Michael Lifshitz; Stephane Richard-Devantoy; Kyle T.},
journal = {Current Treatment Options in Rheumatology},
year = {2026},
url = {https://www.nature.com/articles/s43856-026-01987-8}
}
Purpose The engineered v5.9 DNA polymerase has been reported to exhibit enhanced thermostability in loop-mediated isothermal amplification (LAMP). As an initial step toward field-deployable molecular diagnosis of giardiasis, we...
Background Polygenic risk scores for cardiovascular disease show poor agreement between methods, and most treat sex as a covariate rather than stratifying by it, despite well-documented sex differences in disease incidence and outcomes....
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication...
Cognitive tests are commonly used to evaluate the effects of cognitive and exercise interventions in Parkinson’s disease, but their ability to distinguish genuine change from measurement variability remains insufficiently characterized....